SVG Sprites

Press

LDPN in the News 07.15.2020

Moncef Slaoui is allowed to maintain drug investments under an Inspector General decision

Washington Post – 7/15/20

Monday’s ruling by the Office of Inspector General came in response to a complaint filed by the advocacy groups Public Citizen and Lower Drug Prices Now.

Public Citizen and Lower Drug Prices Now contend there is no basis in law for Slaoui to run Operation Warp Speed without being a full-time government employee or a “special government employee,” a designation that permits the government to tap outside people with unique expertise for up to 130 days.

LDPN in the News 07.15.2020

Chief Vaccine Scientist Will Not Be Forced to Disclose Pharmaceutical Stocks

New York Times, Noah Weiland – 7/15/20

“The basic idea that he’s in a really privileged position with lots of resources to command and that he has a personal financial stake in the industry is really challenging,” said Margarida Jorge, the campaign director for Lower Drug Prices Now. “Everyone can appreciate that Slaoui has expertise in the development of vaccines, but expertise and ethics should not be mutually exclusive.”

Ms. Jorge said that her organization and other watchdog groups were planning to meet Wednesday afternoon to discuss new ways to challenge Dr. Slaoui’s status.

LDPN in the News 07.14.2020

Analysis: 5.4M have lost health insurance during pandemic

POLITICO Pulse – 7/14/20

HHS INSPECTOR GENERAL DISMISSES COMPLAINT AGAINST VACCINE ADVISER — The government watchdog rejected a claim brought by Public Citizen and Lower Drug Prices Now over the appointment of Moncef Slaoui to advise Operation Warp Speed. The groups had argued that Slaoui, who is serving as a private contractor, should be viewed as a political appointee, which would open him up to new disclosures and protections against conflict of interest. 

Before being named to his Operation Warp Speed role, Slaoui was serving on the board of Moderna, the manufacturer of a leading vaccine candidate, and had other financial holdings flagged as conflicts by Public Citizen and Lower Drug Prices Now.

LDPN in the News 07.14.2020

HEALTH CARE BRIEFING: Democrats Target Private Equity Firms

Bloomberg Government – 7/14/20

Groups pushing for Congress to restrict what drugmakers can charge for Covid-19 vaccines and medicines said Democrats should go further than only trying to make them free. “If Congress doesn’t take away monopoly control over prices,” companies will still be able to hike prices and charge Medicare, Medicaid and insurers “exorbitant prices that get shifted to the rest of us” through premiums and taxes, said Margarida Jorge, campaign director for Lower Drug Prices Now.

LDPN in the News 07.13.2020

Is too much hope being put into a coronavirus vaccine?

Yahoo News – 7/13/20

“There’s been little action in Congress on the one thing that actually could get things back to normal: ensuring an affordable COVID-19 vaccine that could curtail the spread of the disease. The first step is obviously the investment we’re already seeing to create the vaccine, but the second step is just as important: regulation and accountability to ensure that medicines we’re paying to develop are accessible to all.” — Margarida Jorge, Marketwatch

LDPN in the News 07.06.2020

Ernst needs to work for common man, not donors 

Des Moines Register – 7/6/20

LTE by Logun Buckley, Alliance for Retired Americans, Waterloo

LDPN in the News 06.30.2020

What We Can Learn From The AIDS Crisis In The Race For A COVID-19 Vaccine

WBUR – 6/30/20

“One campaign fighting for global access and a free vaccine, Free the Vaccine, represents 29 countries and two organizations, Universities Allied for Essential Medicines and the Center for Artistic Activism. Another is Lower Drug Prices Now, a U.S. coalition of nearly 60 social justice organizations.”

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles